ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Retransplantation"

  • 2019 American Transplant Congress

    Long-term Outcomes And The Feasibility Of Kidney Retransplantation In Pediatric Survivors Of Post-transplant Lymphoproliferative Disease

    S. Kizilbash, P. Verghese, B. Chavers

    University of Minnesota, Minneapolis, MN

    *Purpose: Post-transplant lymphoproliferative disease (PTLD) is a serious and life-threatening complication of solid organ transplantation. Long-term graft outcomes and the feasibility of kidney retransplantation in…
  • 2019 American Transplant Congress

    Repeat Liver Transplantation after Failed First Transplant in Childhood: Development of a Retransplant Risk Index

    M. Gupta1, M. Barry2, M. Levine3, K. Olthoff3, A. Shaked3, P. Abt3

    1University of Kentucky, Lexington, KY, 2University of California, San Francisco, San Francisco, CA, 3University of Pennsylvania, Philadelphia, PA

    *Purpose: Most morbidity and mortality after pediatric liver retransplantation (LRTx) occurs in the first 100 days. We studied factors associated with mortality and graft failure…
  • 2019 American Transplant Congress

    Clinical Trial of Allogeneic Islet Transplantation in the Treatment of Diabetes after Renal Transplantation

    W. liang, M. Hu, G. Peng, D. Zhou, C. Zeng, W. Zhou, q. Ye, Z. Wang

    Zhongnan Hospital of Wuhan University, Institute of Hepatobiliary Diseases, Wuhan, China

    *Purpose: Diabetes after renal transplantation is one of the most serious complications after renal transplantation. It has a serious impact to the survival of kidney…
  • 2018 American Transplant Congress

    Livers from Donation after Circulatory Death Donors Can Be Safely Used for Retransplantation

    O. van Leeuwen,1 M. van Reeven,2 J. Erdmann,3 H. Metselaar,4 A. van den Berg,5 B. van Hoek,6 W. Polak,2 R. Porte.1

    1Department of Surgery, University Medical Center Groningen, Groningen, Netherlands; 2Department of Surgery, Erasmus Medical Center, Rotterdam, Netherlands; 3Department of Surgery, Leiden University Medical Center, Leiden, Netherlands; 4Department of Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, Netherlands; 5Department of Gastroenterology and Hepatology, University Medical Center Groningen, Groningen, Netherlands; 6Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, Netherlands.

    Introduction: After donation after circulatory death (DCD) liver transplantation (LT), non-anastomotic biliary strictures (NAS) and early allograft dysfunction (EAD) are more frequently observed than after…
  • 2018 American Transplant Congress

    How Early is Too Early for a Preemptive Kidney Transplant? A Markov Decision Process-Based Retrospective Analysis

    M. Kurt,1 A. Khojandi,2 M. Barah,2 B. Tanriover.3

    1Economic and Data Sciences, Merck Research Labs, North Wales, PA; 2Industrial and Systems Engineering, University of Tennessee, Knoxville, TN; 3Division of Nephrology, UT Southwestern Medical Center, Dallas, TX.

    Purpose: Living-donor preemptive kidney transplantation (PKT) provides survival and financial benefits. However there is no guidelines to assist with PKT timing.Method: We considered the transplant…
  • 2018 American Transplant Congress

    Retransplantation after Living Donor Liver Transplantation: Analysis of Data from the A2ALL Study

    H. Braun, J. Grab, J. Dodge, S. Syed, G. Roll, C. Freise, J. Roberts, N. Ascher.

    Surgery, University of California, San Francisco, San Francisco, CA.

    Living donor liver transplantation (LDLT) is associated with a higher incidence of post-transplant vascular and biliary complications. Outcomes for retransplantation (reLT) after LDLT are not…
  • 2018 American Transplant Congress

    Can Immunosuppression Maintenance after Renal Allograft Failure Prevent Further Sensitization?

    A. Mena-Gutierrez, K. Alquadan, A. Santos, K. Womer, M. Casey.

    University of Florida, Gainesville.

    After renal graft failure, retransplantation(ReTx) becomes more difficult due to sensitization to alloantigens. In 2013, our center opened a specialty clinic to maintain immunosuppression(IS) after…
  • 2018 American Transplant Congress

    Outcome of Second Kidney Transplantation According to Previous Pediatric Donor Type: A Retrospective Cohort Analysis

    K. Phonphok, T. Duong, S. Panombualert, S. Bunnapradist.

    Medicine-Nephrology, UCLA, Los Angeles, CA.

    Background: With the prioritization of age ≤ 18 years old at the time of registration on the kidney transplant waiting list in the United States,…
  • 2018 American Transplant Congress

    Repeat Kidney Transplant Patients with Active Rejection Have Elevated Donor-Derived Cell-Free DNA

    S. Mehta,1 J. Chang,2 T. Hailey,1 D. Hiller,3 M. Grskovic,3 J. Yee,3 R. Mannon.1

    1University of Alabama School of Medicine, Birmingham, AL; 2Columbia University Medical Center, New York, NY; 3CareDx, Brisbane, CA.

    Purpose: Donor-derived cell-free DNA (dd-cfDNA) is an established marker of active rejection in de novo kidney transplant recipients. Here we characterize dd-cfDNA in patients who…
  • 2018 American Transplant Congress

    Comparison of C1Q Binding and Flow Cytometric Crossmatch Results Provides an Accurate Evaluation of Hypersensitive Kidney Transplant Patients

    E. Eksioğlu-Demiralp,1 A. Türkmen,2 B. Yelken,2 S. Görçin,2 O. Elbasi,1 F. Yalçin,3 B. Koçak,2 C. Karatas,4 M. Tuncer,4 M. Altinel.3

    1Tissue Typing and Immunology Laboratory, Memorial Health Group, Istanbul, Turkey; 2Sisli Hospital Transplantation Unit, Memorial Health Group, Istanbul, Turkey; 3Hizmet Hospital Transplantation Unit, Memorial Health Group, Istanbul, Turkey; 4Atasehir Hospital Transplantation Unit, Memorial Health Group, Istanbul, Turkey.

    Measurement of C1q binding to Donor specific antibodies (DSA) gives transplantation chance to hypersensitive patients having non-binding high amount of anti-HLA antibodies. In our series…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 11
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences